Thank You For Your Ongoing Participation In The Pfizer Renoir RSV Vaccine Clinical Study

We believe that developing vaccines is key to furthering healthcare and helping to provide protection from various diseases and illnesses. And it's only with the help of people like you that a potential RSV vaccine could be developed.

Over 30,000 participants in 7 countries around the world are participating in our clinical trial, and we are profoundly grateful to these individuals for their contributions. To our study participants, you are making a difference in the fight against RSV. We thank you for your ongoing participation in the follow-up period of the study.

We are no longer enrolling new volunteers for this study, but we hope you will consider volunteering for our other upcoming vaccine clinical trials. You can learn more here: www.pfizerclinicaltrials.com/our-research/vaccines. Your participation is where breakthroughs begin.

With gratitude,
The Renoir RSV Vaccine Study Team